 |
|
Giant Cell ArteritisCorticosteroids, Temporal Artery Biopsy, and Blindness
David A. Weinberg, MD;
Peter J. Savino, MD;
Robert C. Sergott, MD;
Thomas M. Bosley, MD
Arch Fam Med. 1994;3(7):623-627.
References
Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.
| |
1. Wilson JD, Braunwald E, Isselbacher KJ, et al. Harrison's Principles of Internal Medicine. 12th ed. New York, NY: McGraw-Hill International Book Co; 1991: 1461-1462.
2. Keltner JL. Giant-cell arteritis. Ophthalmology. 1982;89:1101-1110.
PUBMED
3. Hunder GG, Michet CJ. Giant cell arteritis and polymyalgia rheumatica. Clin Rheum Dis. 1985;11:471-483.
PUBMED
4. Goodman BW. Temporal arteritis. Am J Med. 1979;67:839-852.
PUBMED
5. Wagener HP, Hollenhorst RW. The ocular lesions of temporal arteritis. Am J Ophthalmol. 1958;45:617-630.
PUBMED
6. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical and pathologic study. Ann Intern Med. 1978;188:162-167.
7. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555.
PUBMED
8. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade AS. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy-proven patients. J Rheumatol. 1992;19:277-280.
PUBMED
9. McDonnell PJ, Moore GW, Miller NR, Hutchins GM, Green WR. Temporal arteritis: a clinicopathologic study. Ophthalmology. 1986;93:518-530.
PUBMED
10. To KW, Enzer YR, Tsiaras WG. Temporal artery biopsy after one month of corticosteroid therapy. Am J Ophthalmol. 1994;117:265-267.
PUBMED
11. Barton JJS, Corbett JJ. Neuro-ophthalmologic vascular emergencies in the elderly. Clin Geriatr Med. 1991;7:525-548.
PUBMED
12. Burde RM, Savino PJ, Trobe JD. Clinical Decisions in Neuro-ophthalmology. 2nd ed. St Louis, Mo: Mosby—Year Book; 1992:51-56. 13. Graham E, Holland A, Avery A, Ross-Russell RW. Prognosis in giant cell arteritis. BMJ. 1981;282:269-271.
FREE FULL TEXT
14. Rosenfeld SI, Kosmorsky GS, Klingele TG, Burde RM, Cohn EM. Treatment of temporal arteritis with ocular involvement. Am J Med. 1986;80:143-145.
PUBMED
15. Hayreh SS. Anterior ischaemic optic neuropathy: differentiation of arteritic from nonarteritic type and its management. Eye. 1990;4:25-41.
PUBMED
16. Matzkin DC, Slamovits TL, Sachs R, Burde RM. Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis. Ophthalmology. 1992;99:68-71.
PUBMED
17. Jonasson F, Cullen JF, Elton RA. Temporal arteritis: a 14-year epidemiological, clinical and prognostic study. Scott Med J. 1979;11:111-119.
18. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy, VII: incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94:1020-1028.
PUBMED
19. Brownstein S, Nicolle DA, Codere F. Bilateral blindness in temporal arteritis with skip areas. Arch Ophthalmol. 1983;101:388-391.
FREE FULL TEXT
20. Parsons-Smith G. Sudden blindness in cranial arteritis. Br J Ophthalmol. 1959;43:204-216.
FREE FULL TEXT
21. Lipton RB, Solomon S, Wertenbaker C. Gradual loss and recovery of vision in temporal arteritis. Arch Intern Med. 1985;145:2252-2253.
FREE FULL TEXT
22. Cullen JF, Coleiro J. Ophthalmic complications of giant cell arteritis: a review. Surv Ophthalmol. 1976;20:247-260.
PUBMED
23. Delecoeuillerie G, Joly P, Cohen de Lara A, Paolaggi JB. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11-year survey of 210 patients). Ann Rheum Dis. 1988;47:733-739.
FREE FULL TEXT
24. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis, I: steroid regimens in the first two months. Ann Rheum Dis. 1989;48:658-661.
FREE FULL TEXT
25. Lundberg I, Hedfors E. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis. J Rheumatol. 1990;17:1340-1345.
PUBMED
26. Clearkin LG. IV steroids for central retinal artery occlusion in giant cell arteritis. Ophthalmology. 1992;99:1482-1483.
PUBMED
27. Myles AB, Perera T, Ridley MG. Prevention of blindness in giant cell arteritis by corticosteroid treatment. Br J Rheumatol. 1992;31:103-105.
FREE FULL TEXT
28. Diamond JP. IV steroid treatment of giant cell arteritis. Ophthalmology. 1993;100:291-292.
PUBMED
29. Huston KA, Hunder GG. Giant cell (cranial) arteritis: a clinical review. Am Heart J. 1980;100:99-107.
PUBMED
30. Diamond JP. Treatable blindness in temporal arteritis. Br J Ophthalmol. 1991;75:432.
FREE FULL TEXT
31. Slamovits TL, Matzkin DC, Burde RM, Sachs R. Author's reply. Ophthalmology. 1992;99:1483-1484.
32. Cohen DN, Smith TR. Skip areas in temporal arteritis: myth versus fact. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:772-783.
33. Albert DM, Ruchman MC, Keltner JL. Skip areas in temporal arteritis. Arch Ophthalmol. 1976;94:2072-2077.
FREE FULL TEXT
34. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc. 1976;51:504-510.
PUBMED
35. Glaser JS. Topical diagnosis: prechiasmal visual pathways. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Philadelphia, Pa: JB Lippincott; 1989;2:chap 5. 36. Barnes MP, Bateman DE, Cleland PG, et al. Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry. 1985;48:157-159.
FREE FULL TEXT
37. Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986;104:847-851.
FREE FULL TEXT
38. McCluskey P, Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987;105:793-797.
FREE FULL TEXT
39. Milligan NM, Newcombe R, Compston DAS. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis, I: clinical effects. J Neurol Neurosurg Psychiatry. 1987;50:511-516.
FREE FULL TEXT
40. Lyons PR, Newman PK, Saunders M. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects. J Neurol Neurosurg Psychiatry. 1988;51:285-287.
FREE FULL TEXT
41. Radia M, Furst DE. Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis. J Rheumatol. 1988;15:242-246.
PUBMED
42. Spoor TC, Rockwell DL. Treatment of optic neuritis with intravenous megadose corticosteroids: a consecutive series. Ophthalmology. 1988;95:131-134.
PUBMED
43. Chrousos GA, Kattah JC, Beck RW, Cleary PA, the Optic Neuritis Study Group. Side effects of glucocorticoid treatment: experience of the Optic Neuritis Treatment Trial. JAMA. 1993;269:2110-2112.
FREE FULL TEXT
|
